(Q36960256)

17 August 2017

1 reference

title

Malignancy and rheumatoid arthritis (English)

1 reference

17 August 2017

0 references

Johan Askling

1

1 reference

17 August 2017

publication date

1 October 2007

1 reference

Current Rheumatology Reports

17 August 2017

published in

1 reference

17 August 2017

volume

9

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

421-426

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-007-0067-1

17 August 2017

exact match

0 references

cites work

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

1 reference

12 December 2020

A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer.

1 reference

12 December 2020

Smoking as a trigger for inflammatory rheumatic diseases

1 reference

12 December 2020

Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.

1 reference

12 December 2020

The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation

1 reference

12 December 2020

Risk of malignancy among patients with rheumatic conditions

1 reference

12 December 2020

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

1 reference

12 December 2020

TNF-alpha in promotion and progression of cancer

1 reference

12 December 2020

NF-kappaB: tumor promoter or suppressor?

1 reference

12 December 2020

Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis

1 reference

12 December 2020

Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis

1 reference

12 December 2020

Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases

1 reference

12 December 2020

Characteristics and survival of 26 patients with paraneoplastic arthritis

1 reference

12 December 2020

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

12 December 2020

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study

1 reference

12 December 2020

Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype

1 reference

12 December 2020

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

1 reference

12 December 2020

Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer

1 reference

12 December 2020

Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety

1 reference

12 December 2020

Etanercept plus standard therapy for Wegener's granulomatosis

1 reference

12 December 2020

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

1 reference

12 December 2020

Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the Province of Saskatchewan, Canada.

1 reference

12 December 2020

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

1 reference

12 December 2020

Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.

1 reference

12 December 2020

Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis

1 reference

12 December 2020

Rheumatoid arthritis and cancer risk

1 reference

12 December 2020

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis

1 reference

12 December 2020

Incidence of cancer among patients with knee implants in Sweden, 1980-1994.

1 reference

12 December 2020

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression

1 reference

12 December 2020

Cancer among children of parents with autoimmune diseases.

1 reference

12 December 2020

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence

1 reference

12 December 2020

Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide

1 reference

12 December 2020

Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives

1 reference

12 December 2020

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients

1 reference

12 December 2020

Influence of inflammatory polyarthritis on cancer incidence and survival: results from a community-based prospective study

1 reference

12 December 2020

Non-Hodgkin's lymphoma--meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories

1 reference

12 December 2020

Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis

1 reference

12 December 2020

Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study

1 reference

12 December 2020

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration

1 reference

12 December 2020

Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland

1 reference

12 December 2020

10.1007/S11926-007-0067-1

Identifiers

DOI

1 reference

17 August 2017

1 reference